Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer
In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX
Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks
NCI’s Goal To Increase Minority Participation In Trials, Sondik Says
UT Southwestern, M.D. Anderson Form Cancer Center In Dallas
NCI Scientists Immunize A Healthy BMT Donor Against Myeloma
Trending Stories
- Federal judge blocks Trump administration’s move to limit indirect costs to 15% for NIH-funded institutions
The move could gut academic cancer research - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - “Page Not Found:” HHS agencies purge web pages that hint at DEI, health equity, and gender
Medical group sues over removing “information used every day by health professions” - Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills